Quadrant Capital Group LLC
- SEC CIK
- 0001650717
- Latest filing
- Aug 14, 2026
CGEM holding history
Cullinan Therapeutics, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CGEM overviewAll 13F holders of CGEMFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −761−100.0% | Sold out | Holders |
| Q1 2026 | 761 | $10.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 761 | $7.88K | <0.1% | −143−15.8% | Reduced | Holders |
| Q3 2025 | 904 | $5.36K | <0.1% | +904 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −2,972−100.0% | Sold out | Holders |
| Q1 2025 | 2,972 | $22.5K | <0.1% | +2,731+1,133.2% | Added | Holders |
| Q4 2024 | 241 | $2.94K | <0.1% | −20−7.7% | Reduced | Holders |
| Q3 2024 | 261 | $4.37K | <0.1% | −27−9.4% | Reduced | Holders |
| Q2 2024 | 288 | $5.02K | <0.1% | −18−5.9% | Reduced | Holders |
| Q1 2024 | 306 | $5.21K | <0.1% | +65+27.0% | Added | Holders |
| Q4 2023 | 241 | $2.46K | <0.1% | +241 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −631−100.0% | Sold out | Holders |
| Q4 2022 | 631 | $6.66K | <0.1% | +631 | New | Holders |